| 51 |
19915943 | Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis. | 2010 Apr |
3 |
| 52 |
20136356 | Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis. | 2010 Feb |
1 |
| 53 |
20533531 | In vivo expansion of MDR1-transduced cells accompanied by a post-transplantation chemotherapy regimen with mitomycin C and methotrexate. | 2010 Jul |
2 |
| 54 |
17660216 | Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. | 2008 Mar |
1 |
| 55 |
18336795 | Role of proline 1150 in functional interactions between the membrane spanning domains and nucleotide binding domains of the MRP1 (ABCC1) transporter. | 2008 Apr 15 |
1 |
| 56 |
17982279 | Cobalamin potentiates vinblastine cytotoxicity through downregulation of mdr-1 gene expression in HepG2 cells. | 2007 |
1 |
| 57 |
16504991 | Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug. | 2006 Oct |
12 |
| 58 |
16932953 | The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs. | 2006 Nov |
1 |
| 59 |
17181924 | ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients. | 2006 Sep-Oct |
2 |
| 60 |
15703814 | Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer. | 2005 Mar |
1 |
| 61 |
16259774 | Involvement of P-glycoprotein in the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. | 2005 Nov |
2 |
| 62 |
16321374 | Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. | 2005 Dec 28 |
2 |
| 63 |
15110230 | P-glycoprotein in autoimmune diseases. | 2004 Mar |
1 |
| 64 |
12687290 | Ketotifen reverses MDR1-mediated multidrug resistance in human breast cancer cells in vitro and alleviates cardiotoxicity induced by doxorubicin in vivo. | 2003 May |
1 |
| 65 |
12466237 | The use of Tris-lipidation to modify drug cytotoxicity in multidrug resistant cells expressing P-glycoprotein or MRP1. | 2002 Dec |
1 |
| 66 |
11721885 | Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution. | 2001 |
2 |
| 67 |
10664539 | Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. | 2000 Jan |
3 |
| 68 |
10902777 | Increased MDR1 P-glycoprotein expression in methotrexate resistance: comment on the article by Yudoh et al. | 2000 Jul |
2 |
| 69 |
10075817 | A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles. | 1999 Mar 15 |
1 |
| 70 |
10430334 | A case of colon cancer recurrence with P-glycoprotein treated by methotrexate, fluorouracil, and leucovorin. | 1999 May-Jun |
1 |
| 71 |
9754649 | P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene. | 1998 Oct 5 |
12 |
| 72 |
8598312 | Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate. | 1996 Mar 1 |
4 |
| 73 |
8911123 | Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line. | 1996 Aug |
1 |
| 74 |
7848886 | P-glycoprotein expression in primary and metastatic transitional cell carcinoma of the bladder. | 1994 Nov |
1 |
| 75 |
7912069 | P-glycoprotein overexpression in methotrexate-resistant Leishmania tropica. | 1994 Jun 1 |
1 |